- Plexus (PLXS, Financial) reports fiscal Q2 2025 revenue of $980 million with a GAAP diluted EPS of $1.41.
- Non-GAAP EPS of $1.66 exceeds company guidance, showing significant profitability growth.
- Guidance for Q3 2025 anticipates revenue of $1.00-1.04 billion and non-GAAP EPS of $1.65-1.80.
Plexus Corp. (PLXS) announced robust financial results for its fiscal second quarter of 2025, reporting a revenue of $980 million. The company achieved a GAAP operating margin of 5.0% and a GAAP diluted EPS of $1.41. Notably, the non-GAAP EPS reached $1.66, exceeding its guidance range of $1.46-$1.61, highlighting effective operational efficiency initiatives.
The quarter also marked strong performance in new business acquisitions, with Plexus winning 42 manufacturing programs, which are expected to generate $205 million in annualized revenue when fully ramped. The diversified business mix saw contributions from Healthcare/Life Sciences (42%), Industrial (40%), and Aerospace/Defense (18%).
Free cash flow generation was $16.5 million for the quarter, with $12.2 million allocated for share repurchases at an average price of $141.18 per share. This initiative is part of the remaining $25.0 million authorization under the current $50.0 million share repurchase program.
Looking ahead to fiscal Q3 2025, Plexus projects revenue to grow sequentially to $1.00-1.04 billion. The company has provided a guidance for GAAP diluted EPS of $1.40-1.55 and a non-GAAP EPS of $1.65-1.80. Plexus maintains a positive outlook for fiscal 2025, expecting meaningful EPS growth across all market sectors despite acknowledging tariff-related uncertainties.
Plexus' strong return on invested capital (ROIC) of 13.7% underscores its strategic focus and effective capital management, further enhancing shareholder value. The company's operational excellence continues to drive its strategic investments, enabling sustained customer success globally.
